Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

NV-1020 enters phase I/II study for liver metastases

Sep. 7, 2004

Suppression of testosterone by abiraterone acetate in prostate cancer patients

Sep. 7, 2004

Bolder Biotechnology receives SBIR grants for oncology efforts

Sep. 6, 2004

Celsion cleared to conduct phase I study of ThermoDox in liver cancer

Sep. 3, 2004

MGI Pharma and SuperGen sign license agreement for Dacogen

Sep. 3, 2004

Satraplatin plus radiation therapy studies in phase I/II trial for NSCLC

Sep. 3, 2004

Scandinavian phase II trial of Alpharadin extended to U.K.

Sep. 2, 2004

IC-MedTech licenses Apatone

Sep. 2, 2004

New mitotic kinesin KSP inhibitors discovered by Merck researchers

Sep. 2, 2004

Takeda develops new metastin derivatives for preventing cancer metastasis

Sep. 2, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...